Earlier this month, research outcomes confirmed that molnupiravir, Merck’s investigational antiviral tablet, minimize hospitalization charges of Covid-19 sufferers by about half. Molnupiravir is the primary oral remedy that has proven promise in treating Covid-19. One other antiviral, remdesivir, can solely be administered intravenously.
“Having an oral possibility might be an enormous change,” stated Benjamin Gewurz, affiliate director of the Ph.D. program in virology at Harvard Medical Faculty. “Some individuals might simply take a tablet reasonably than having an IV or injection of some type. And that’s what could be an enormous, large advance.”
This video explains precisely how this drug works within the physique to fight the coronavirus.